LP view · Centennial AI Global Equity Fund
Indexed to 100 · 36 months · ASX 200 TR
Period: Jan 1 – Apr 8, 2026
| Beginning NAV (Jan 1) | $50,200,000 |
| Capital Calls | +$0 |
| Capital Distributions | -$0 |
| Investment Gains | +$2,647,234 |
| Management Fees | -$105,000 |
| Performance Fees | -$0 (below hurdle) |
| Ending NAV | $52,742,234 |
| Period Return | +5.27% |
Capital Calls
| Jan 2020 | $15,000,000 | Initial |
| Mar 2020 | $10,000,000 | Call #1 |
| Oct 2020 | $7,000,000 | Call #2 |
| Feb 2022 | $5,000,000 | Call #3 |
| Sep 2023 | $5,000,000 | Call #4 |
| Total Called | $42,000,000 | of $50M |
| Uncalled | $8,000,000 |
Distributions
| 2021 | $1,200,000 | Tax dist. |
| 2023 | $2,000,000 | Return of capital |
| Total | $3,200,000 |
Quarterly letters, financial statements, tax documents
Q4 2025 Investor Letter
NEWQ3 2025 Investor Letter
Q2 2025 Investor Letter
Q1 2025 Investor Letter
2025 Annual Report
2025 Audited Financials
2025 K-1 Tax Document
Private Placement Memorandum
Limited Partnership Agreement
Subscription Agreement
Form ADV Part 2
Fund Fact Sheet Q4 2025
Net Return
+8.72%
Benchmark
+4.40%
Alpha
+4.32%
Click to expand
Strong finish to the year as our quality bias paid off in the December rally. Positions in CSL and Macquarie drove outsized returns versus the benchmark.
Portfolio navigated August volatility well, focused on capital preservation. Defensive positioning in healthcare and utilities cushioned the drawdown.
Added to Healthcare positions as valuations improved post-budget. Trimmed bank exposure ahead of anticipated margin compression in H2.
Annual LP Meeting
June 15, 2026 · Sydney
Q1 2026 Investor Letter
Published April 30
Q1 2026 Audited NAV
May 10, 2026
Capital Call #5 (tentative)
Q3 2026